Clinical Trial Update: Biomarker for Infection Risk in CLL and MM

View source ↗

Summary

This update describes a biomarker study to assess infection risk in patients with multiple myeloma and chronic lymphocytic leukemia. The trial is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Multiple Myeloma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma, Chronic Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING